This document shares learnings from an assessment of the global syringe market capacity to help ensure production volumes can be secured with no delay for the 92 low and lower middle income countries that will be rolling out vaccines under the COVAX Advance Market Commitment. Products covered include auto disable and reuse prevention syringes, prefilled delivery devices, and safety boxes. This brief was completed in December, 2020.